Lexicon Pharmaceuticals
Home
Contact Us
Site Map
About Us
About Us Home
Management Team
Board of Directors
Development Team
Locations
Contact Us
History
Pipeline
Drug Pipeline Home
Our Goal
Therapeutic Areas
Drug Development Team
Clinical Trials
Publications
Discovery
Discovery Home
Discovery Process
Technology
Genome5000
Medicinal Chemistry
Patents
Academic Access
Technology Licensing
Scientific Publications
Alliances
Alliances Home
Current Alliances
Technology Licensing
Careers
Careers Home
Opportunities
Our Culture
Benefits
Community Involvement
The Woodlands
Princeton
Awards and Recognition
News
News Home
Media Inquiries
Investors
Investors Home
Media
Events
Stock Quote
SEC Filings
Annual Reports
Corporate Governance
Request Information
News Home
Media Inquiries
Subscribe
Press Releases
Filter
Display #
5
10
15
20
25
30
50
100
All
02/08/2011
Lexicon Pharmaceuticals to Present at the 13th Annual BIO CEO & Investor Conference
01/06/2011
Lexicon Announces Positive Results from New Clinical Study of LX4211 in Type 2 Diabetes Patients
01/04/2011
Lexicon Pharmaceuticals to Present at the 29th Annual J.P. Morgan Healthcare Conference
12/14/2010
Lexicon Announces Top-Line Phase 2a Data for LX2931 in Patients with Rheumatoid Arthritis
11/30/2010
Lexicon Pharmaceuticals to Present at 5th Annual Canaccord Genuity Cardiovascular, Diabetes & Obesity Conference
11/05/2010
Lexicon Pharmaceuticals Provides Clinical Pipeline Update and Reports 2010 Third Quarter Financial Results
10/26/2010
Lexicon to Provide Clinical Pipeline Update and Report Third Quarter 2010 Financial Results
10/12/2010
Lexicon Pharmaceuticals to Present at BioCentury Newsmakers in the Biotech Industry Conference Oct 22nd
09/09/2010
Lexicon to Present at Stifel Nicolaus Healthcare Conference
09/07/2010
Lexicon to present at Morgan Stanley Global Healthcare Conference
«
Start
Prev
1
2
3
4
5
6
7
8
9
10
Next
End
»
Page 4 of 41
